IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung Cancer

Xin Chen(Zigong First People's Hospital), Qi Zhu(Zigong First People's Hospital)
International Journal of General Medicine
December 1, 2023
Cited by 6


Related Papers